Barry Diller Launches $12.4 Billion Bid to Take MGM Resorts Private
MGM says the offer undervalues the company as takeover talks continue.
Already have an account? Sign in.
MGM says the offer undervalues the company as takeover talks continue.
BE reported 138% revenue growth and raised guidance, yet shares fell on high expectations, stretched valuation, and negative operating cash flow optics.
TD Cowen calls Phase 3 intismeran + Keytruda results “compelling” and in the exceptional range. Wells Fargo says RFS exceeded expectations.
Biohaven’s Vyglxia resubmission for SCA accepted for review by the FDA. Target action date is the first quarter of 2027.
Be the first to know when deals break, stocks move, or biotech headlines hit.